LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)

Thierry Conroy, Pascal Hammel, Anthony Turpin, Christine Belletier, Alice C. Wei, Emmanuel Mitry, Anthony Lopez, Éric François, Pascal Artru, James Biagi, Thierry Lecomte, Eric Assénat, Roger Faroux, Marc Ychou, Olivier Bouché, Aurélien Lambert, Laure Monard, Patrick Rat, Florence Castan, J-B. Bachet